LifeStance Health Group, Inc. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
LifeStance Health Group, Inc. (LFST) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $19.75 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-06
- LifeStance Health Group, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $19.75M, a 6.48% decline year-over-year.
- LifeStance Health Group, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $15.20M, a 18.20% decline year-over-year.
- LifeStance Health Group, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-12-31 was $16.70M, a 3.46% increase year-over-year.
- LifeStance Health Group, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $18.30M, a 22.84% increase year-over-year.
- LifeStance Health Group, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $74.70M, a 1.93% decline from fiscal 2024.
- LifeStance Health Group, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $76.17M, a 25.89% decline from fiscal 2023.
- LifeStance Health Group, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $102.79M, a 45.55% decline from fiscal 2022.
- LifeStance Health Group, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $188.79M, a 27.23% decline from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $19.75M 10-Q · filed 2026-08-06 | $34.95M 10-Q · filed 2026-08-06 | $51.65M derived: sum of 3 quarters · filed 2026-08-06 | $69.95M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $15.20M 10-Q · filed 2026-05-07 | $31.91M derived: sum of 2 quarters · filed 2026-05-07 | $50.20M derived: sum of 3 quarters · filed 2026-05-07 | $71.32M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $16.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $35.00M derived: sum of 2 quarters · filed 2026-02-25 | $56.12M derived: sum of 3 quarters · filed 2026-08-06 | $74.70M 10-K · filed 2026-02-25 |
| 2025-09-30 | $18.30M 10-Q · filed 2025-11-06 | $39.41M derived: sum of 2 quarters · filed 2026-08-06 | $58.00M 10-Q · filed 2025-11-06 | $74.14M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $21.12M 10-Q · filed 2026-08-06 | $39.70M 10-Q · filed 2026-08-06 | $55.85M derived: sum of 3 quarters · filed 2026-08-06 | $70.74M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $18.58M 10-Q · filed 2026-05-07 | $34.73M derived: sum of 2 quarters · filed 2026-05-07 | $49.63M derived: sum of 3 quarters · filed 2026-05-07 | $74.17M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $16.15M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $31.04M derived: sum of 2 quarters · filed 2026-02-25 | $55.59M derived: sum of 3 quarters · filed 2026-02-25 | $76.17M 10-K · filed 2026-02-25 |
| 2024-09-30 | $14.89M 10-Q · filed 2025-11-06 | $39.45M derived: sum of 2 quarters · filed 2025-11-06 | $60.03M 10-Q · filed 2025-11-06 | $80.94M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $24.55M 10-Q · filed 2025-08-07 | $45.13M 10-Q · filed 2025-08-07 | $66.05M derived: sum of 3 quarters · filed 2026-02-25 | $87.58M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $20.58M 10-Q · filed 2025-05-07 | $41.50M derived: sum of 2 quarters · filed 2026-02-25 | $63.02M derived: sum of 3 quarters · filed 2026-02-25 | $96.14M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $20.92M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $42.44M derived: sum of 2 quarters · filed 2026-02-25 | $75.56M derived: sum of 3 quarters · filed 2026-02-25 | $102.79M 10-K · filed 2026-02-25 |
| 2023-09-30 | $21.52M 10-Q · filed 2024-11-07 | $54.64M derived: sum of 2 quarters · filed 2024-11-07 | $81.87M 10-Q · filed 2024-11-07 | $117.37M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $33.11M 10-Q · filed 2024-08-08 | $60.34M 10-Q · filed 2024-08-08 | $95.85M derived: sum of 3 quarters · filed 2025-02-27 | $131.58M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $27.23M 10-Q · filed 2024-05-09 | $62.74M derived: sum of 2 quarters · filed 2025-02-27 | $98.47M derived: sum of 3 quarters · filed 2025-02-27 | $155.98M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $35.51M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $71.24M derived: sum of 2 quarters · filed 2025-02-27 | $128.75M derived: sum of 3 quarters · filed 2025-02-27 | $188.79M 10-K · filed 2025-02-27 |
| 2022-09-30 | $35.73M 10-Q · filed 2023-11-08 | $93.25M derived: sum of 2 quarters · filed 2023-11-08 | $153.28M 10-Q · filed 2023-11-08 | $261.92M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $57.51M 10-Q · filed 2023-08-09 | $117.55M 10-Q · filed 2023-08-09 | $226.18M derived: sum of 3 quarters · filed 2024-02-28 | $346.87M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $60.04M 10-Q · filed 2023-05-10 | $168.67M derived: sum of 2 quarters · filed 2024-02-28 | $289.36M derived: sum of 3 quarters · filed 2024-02-28 | $318.87M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $108.63M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $229.32M derived: sum of 2 quarters · filed 2024-02-28 | $258.83M derived: sum of 3 quarters · filed 2024-02-28 | $259.44M 10-K · filed 2024-02-28 |
| 2021-09-30 | $120.69M 10-Q · filed 2022-11-09 | $150.20M derived: sum of 2 quarters · filed 2022-11-09 | $150.81M 10-Q · filed 2022-11-09 | $151.40M derived: sum of 4 quarters · filed 2023-03-09 |
| 2021-06-30 | $29.52M 10-Q · filed 2022-08-10 | $30.12M 10-Q · filed 2022-08-10 | $30.71M derived: sum of 3 quarters · filed 2023-03-09 | $31.28M derived: sum of 4 quarters · filed 2023-03-09 |
| 2021-03-31 | $605.00K 10-Q · filed 2022-05-11 | $1.19M derived: sum of 2 quarters · filed 2023-03-09 | $1.76M derived: sum of 3 quarters · filed 2023-03-09 | $2.06M derived: sum of 4 quarters · filed 2023-03-09 |
| 2020-12-31 | $587.00K derived: 10-K 9 month − 10-Q 6 month · filed 2023-03-09 | $1.16M derived: sum of 2 quarters · filed 2023-03-09 | $1.45M 10-K · filed 2023-03-09 | |
| 2020-09-30 | $573.00K 10-Q · filed 2021-11-10 | $865.00K 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | $292.00K 10-Q · filed 2021-08-12 | |||
| 2019-12-31 | $54.00K 10-K · filed 2022-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |